Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in Benin and Mali
Open Access
- 1 September 2017
- Vol. 7 (9), e016590
- https://doi.org/10.1136/bmjopen-2017-016590
Abstract
Objective To assess the effectiveness of low-cost uterine tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage (PPH) in low-resource settings. Design Randomised controlled trial. Setting Seven healthcare facilities in Cotonou, Benin and Bamako, Mali. Population Women delivering vaginally who had clinically diagnosed PPH that was suspected to be due to uterine atony, who were unresponsive to oxytocin and who needed additional uterotonics. Methods Women were randomly assigned to receive uterine balloon tamponade with a condom-catheter device or no tamponade; both groups were also given intrarectal or sublingual misoprostol. Main outcome measure Proportion of women with invasive surgery or who died before hospital discharge. Results The proportion of primary composite outcome did not differ significantly between the tamponade arm (16%; 9/57) and the standard second line treatment arm (7%; 4/59): relative risk 2.33 (95% CI 0.76 to 7.14, p=0.238). A significantly increased proportion of women with tamponade and misoprostol versus misoprostol alone had total blood loss more than 1000 mL: relative risk 1.52 (95% CI 1.15 to 2.00, p=0.01). Case fatality rate was higher in the tamponade group (10%; 6/57) than in the control group (2%; 1/59) (p=0.059). Trial registration number ISRCT Registry Number 01202389; Post-results.Keywords
Funding Information
- French Research Institute for Development
- UNICEF
This publication has 20 references indexed in Scilit:
- Condom-catheter tamponade for the treatment of postpartum haemorrhage and factors associated with success: a prospective observational studyBJOG: An International Journal of Obstetrics and Gynaecology, 2016
- Diversity and divergence: the dynamic burden of poor maternal healthThe Lancet, 2016
- Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planningInternational Journal of Women's Health, 2016
- A postpartum haemorrhage package with condom uterine balloon tamponade: a prospective multi‐centre case series in Kenya, Sierra Leone, Senegal, and NepalBJOG: An International Journal of Obstetrics and Gynaecology, 2015
- Treatment for primary postpartum haemorrhageCochrane Database of Systematic Reviews, 2014
- Trends in the rate of invasive procedures after the addition of the intrauterine tamponade test to a protocol for management of severe postpartum hemorrhageAmerican Journal of Obstetrics and Gynecology, 2012
- Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource‐poor settings: a systematic reviewBJOG: An International Journal of Obstetrics and Gynaecology, 2012
- Intraluminal pressure readings during the establishment of a positive ‘tamponade test’ in the management of postpartum haemorrhageBJOG: An International Journal of Obstetrics and Gynaecology, 2010
- Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effectsBulletin of the World Health Organization, 2009
- Le misoprostol par voie rectale dans l'hémorragie de la délivranceGynécologie Obstétrique & Fertilité, 2004